Back to results
CompletedPhase 1

A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

NCT03289962

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

HonorHealth Research Institute ? Bisgrove

Scottsdale, Arizona, United States

+25 additional locations

View on ClinicalTrials.gov